Global and Japan Pneumonia Vaccine Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Oct-2020
No. of pages: 127
Inquire Before Buying

Pneumonia Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Pneumonia Vaccine market is segmented into

Pneumococcal Conjugate Vaccine (PCV13)

Pneumococcal Polysaccharide Vaccine (PPSV23)

Segment by Application, the Pneumonia Vaccine market is segmented into

Pneumonia

Meningitis

Sepsis

Regional and Country-level Analysis

The Pneumonia Vaccine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Pneumonia Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pneumonia Vaccine Market Share Analysis

Pneumonia Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumonia Vaccine business, the date to enter into the Pneumonia Vaccine market, Pneumonia Vaccine product introduction, recent developments, etc.

The major vendors covered:

Pfizer Inc.

Glaxosmithkline Plc.

Merck & Co., Inc.

Sanofi Pasteur

Serum Institute of India Pvt. Ltd.

Johnson & Johnson

Astellas Pharma Inc.

Astrazeneca Plc.

CSL Limited

Emergent Biosolutions

Global and Japan Pneumonia Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pneumonia Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pneumonia Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pneumonia Vaccine Market Size Growth Rate by Type
1.4.2 Pneumococcal Conjugate Vaccine (PCV13)
1.4.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.5 Market by Application
1.5.1 Global Pneumonia Vaccine Market Size Growth Rate by Application
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Sepsis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pneumonia Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Pneumonia Vaccine Revenue 2015-2026
2.1.2 Global Pneumonia Vaccine Sales 2015-2026
2.2 Global Pneumonia Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pneumonia Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Pneumonia Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pneumonia Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pneumonia Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pneumonia Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Pneumonia Vaccine Revenue Forecast by Region (2021-2026)
3 Global Pneumonia Vaccine Competitor Landscape by Players
3.1 Global Top Pneumonia Vaccine Sales by Manufacturers
3.1.1 Global Pneumonia Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Pneumonia Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pneumonia Vaccine Manufacturers by Revenue
3.2.1 Global Pneumonia Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Pneumonia Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pneumonia Vaccine Revenue in 2019
3.2.5 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pneumonia Vaccine Price by Manufacturers
3.4 Global Pneumonia Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumonia Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumonia Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pneumonia Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumonia Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pneumonia Vaccine Sales by Type (2015-2020)
4.1.2 Global Pneumonia Vaccine Revenue by Type (2015-2020)
4.1.3 Pneumonia Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pneumonia Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pneumonia Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pneumonia Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pneumonia Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pneumonia Vaccine Sales by Application (2015-2020)
5.1.2 Global Pneumonia Vaccine Revenue by Application (2015-2020)
5.1.3 Pneumonia Vaccine Price by Application (2015-2020)
5.2 Pneumonia Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumonia Vaccine Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Pneumonia Vaccine Market Size YoY Growth 2015-2026
6.1.1 Japan Pneumonia Vaccine Sales YoY Growth 2015-2026
6.1.2 Japan Pneumonia Vaccine Revenue YoY Growth 2015-2026
6.1.3 Japan Pneumonia Vaccine Market Share in Global Market 2015-2026
6.2 Japan Pneumonia Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Pneumonia Vaccine Players by Sales (2015-2020)
6.2.2 Japan Top Pneumonia Vaccine Players by Revenue (2015-2020)
6.3 Japan Pneumonia Vaccine Historic Market Review by Type (2015-2020)
6.3.1 Japan Pneumonia Vaccine Sales Market Share by Type (2015-2020)
6.3.2 Japan Pneumonia Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 Japan Pneumonia Vaccine Price by Type (2015-2020)
6.4 Japan Pneumonia Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Pneumonia Vaccine Sales Forecast by Type (2021-2026)
6.4.2 Japan Pneumonia Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 Japan Pneumonia Vaccine Price Forecast by Type (2021-2026)
6.5 Japan Pneumonia Vaccine Historic Market Review by Application (2015-2020)
6.5.1 Japan Pneumonia Vaccine Sales Market Share by Application (2015-2020)
6.5.2 Japan Pneumonia Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 Japan Pneumonia Vaccine Price by Application (2015-2020)
6.6 Japan Pneumonia Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Pneumonia Vaccine Sales Forecast by Application (2021-2026)
6.6.2 Japan Pneumonia Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 Japan Pneumonia Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pneumonia Vaccine Market Size YoY Growth 2015-2026
7.2 North America Pneumonia Vaccine Market Facts & Figures by Country
7.2.1 North America Pneumonia Vaccine Sales by Country (2015-2020)
7.2.2 North America Pneumonia Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pneumonia Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Pneumonia Vaccine Market Facts & Figures by Country
8.2.1 Europe Pneumonia Vaccine Sales by Country
8.2.2 Europe Pneumonia Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pneumonia Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Pneumonia Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Pneumonia Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pneumonia Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Pneumonia Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pneumonia Vaccine Sales by Country
10.2.2 Latin America Pneumonia Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pneumonia Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pneumonia Vaccine Sales by Country
11.2.2 Middle East and Africa Pneumonia Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Corporation Information
12.1.2 Pfizer Inc. Description and Business Overview
12.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
12.1.5 Pfizer Inc. Recent Development
12.2 Glaxosmithkline Plc.
12.2.1 Glaxosmithkline Plc. Corporation Information
12.2.2 Glaxosmithkline Plc. Description and Business Overview
12.2.3 Glaxosmithkline Plc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
12.2.5 Glaxosmithkline Plc. Recent Development
12.3 Merck & Co., Inc.
12.3.1 Merck & Co., Inc. Corporation Information
12.3.2 Merck & Co., Inc. Description and Business Overview
12.3.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
12.3.5 Merck & Co., Inc. Recent Development
12.4 Sanofi Pasteur
12.4.1 Sanofi Pasteur Corporation Information
12.4.2 Sanofi Pasteur Description and Business Overview
12.4.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
12.4.5 Sanofi Pasteur Recent Development
12.5 Serum Institute of India Pvt. Ltd.
12.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
12.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
12.5.3 Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
12.5.5 Serum Institute of India Pvt. Ltd. Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Astellas Pharma Inc.
12.7.1 Astellas Pharma Inc. Corporation Information
12.7.2 Astellas Pharma Inc. Description and Business Overview
12.7.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
12.7.5 Astellas Pharma Inc. Recent Development
12.8 Astrazeneca Plc.
12.8.1 Astrazeneca Plc. Corporation Information
12.8.2 Astrazeneca Plc. Description and Business Overview
12.8.3 Astrazeneca Plc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
12.8.5 Astrazeneca Plc. Recent Development
12.9 CSL Limited
12.9.1 CSL Limited Corporation Information
12.9.2 CSL Limited Description and Business Overview
12.9.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
12.9.4 CSL Limited Pneumonia Vaccine Products Offered
12.9.5 CSL Limited Recent Development
12.10 Emergent Biosolutions
12.10.1 Emergent Biosolutions Corporation Information
12.10.2 Emergent Biosolutions Description and Business Overview
12.10.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
12.10.5 Emergent Biosolutions Recent Development
12.11 Pfizer Inc.
12.11.1 Pfizer Inc. Corporation Information
12.11.2 Pfizer Inc. Description and Business Overview
12.11.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Inc. Pneumonia Vaccine Products Offered
12.11.5 Pfizer Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pneumonia Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumonia Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pneumonia Vaccine Market Segments
Table 2. Ranking of Global Top Pneumonia Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pneumonia Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Pneumococcal Conjugate Vaccine (PCV13)
Table 5. Major Manufacturers of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table 6. Global Pneumonia Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Pneumonia Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Pneumonia Vaccine Sales by Regions 2015-2020 (K Doses)
Table 9. Global Pneumonia Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Pneumonia Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Pneumonia Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 12. Global Pneumonia Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Pneumonia Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Vaccine as of 2019)
Table 16. Pneumonia Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pneumonia Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pneumonia Vaccine Price (2015-2020) (USD/Dose)
Table 19. Pneumonia Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pneumonia Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Pneumonia Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)
Table 24. Global Pneumonia Vaccine Sales Share by Type (2015-2020)
Table 25. Global Pneumonia Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pneumonia Vaccine Revenue Share by Type (2015-2020)
Table 27. Pneumonia Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Pneumonia Vaccine Sales Share by Type (2021-2026)
Table 29. Global Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)
Table 30. Global Pneumonia Vaccine Sales Share by Application (2015-2020)
Table 31. Global Pneumonia Vaccine Sales Share by Application (2021-2026)
Table 32. Global Pneumonia Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Pneumonia Vaccine Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Pneumonia Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Pneumonia Vaccine Sales (K Doses) of Key Companies (2015-2020)
Table 36. Japan Pneumonia Vaccine Sales Share by Company (2015-2020)
Table 37. Japan Pneumonia Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Pneumonia Vaccine Sales (K Doses) by Type (2015-2020)
Table 39. Japan Pneumonia Vaccine Sales Share by Type (2015-2020)
Table 40. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Pneumonia Vaccine Price (K Doses) by Type (2015-2020)
Table 42. Japan Pneumonia Vaccine Sales (K Doses) by Type (2021-2026)
Table 43. Japan Pneumonia Vaccine Sales Share by Type (2021-2026)
Table 44. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Pneumonia Vaccine Revenue Share by Type (2021-2026)
Table 46. Japan Pneumonia Vaccine Price (K Doses) by Type (2021-2026)
Table 47. Japan Pneumonia Vaccine Sales (K Doses) by Application (2015-2020)
Table 48. Japan Pneumonia Vaccine Sales Share by Application (2015-2020)
Table 49. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Pneumonia Vaccine Sales (K Doses) by Application (2021-2026)
Table 51. Japan Pneumonia Vaccine Sales Share by Application (2021-2026)
Table 52. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Pneumonia Vaccine Revenue Share by Application (2021-2026)
Table 54. North America Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 55. North America Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 56. North America Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Europe Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 59. Europe Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 60. Europe Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Pneumonia Vaccine Sales by Region (2015-2020) (K Doses)
Table 63. Asia Pacific Pneumonia Vaccine Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Pneumonia Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Pneumonia Vaccine Revenue Market Share by Region (2015-2020)
Table 66. Latin America Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 67. Latin America Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 71. Middle East and Africa Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 74. Pfizer Inc. Corporation Information
Table 75. Pfizer Inc. Description and Business Overview
Table 76. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Pfizer Inc. Pneumonia Vaccine Product
Table 78. Pfizer Inc. Recent Development
Table 79. Glaxosmithkline Plc. Corporation Information
Table 80. Glaxosmithkline Plc. Description and Business Overview
Table 81. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Glaxosmithkline Plc. Product
Table 83. Glaxosmithkline Plc. Recent Development
Table 84. Merck & Co., Inc. Corporation Information
Table 85. Merck & Co., Inc. Description and Business Overview
Table 86. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Merck & Co., Inc. Product
Table 88. Merck & Co., Inc. Recent Development
Table 89. Sanofi Pasteur Corporation Information
Table 90. Sanofi Pasteur Description and Business Overview
Table 91. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Sanofi Pasteur Product
Table 93. Sanofi Pasteur Recent Development
Table 94. Serum Institute of India Pvt. Ltd. Corporation Information
Table 95. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 96. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Serum Institute of India Pvt. Ltd. Product
Table 98. Serum Institute of India Pvt. Ltd. Recent Development
Table 99. Johnson & Johnson Corporation Information
Table 100. Johnson & Johnson Description and Business Overview
Table 101. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Recent Development
Table 104. Astellas Pharma Inc. Corporation Information
Table 105. Astellas Pharma Inc. Description and Business Overview
Table 106. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Astellas Pharma Inc. Product
Table 108. Astellas Pharma Inc. Recent Development
Table 109. Astrazeneca Plc. Corporation Information
Table 110. Astrazeneca Plc. Description and Business Overview
Table 111. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Astrazeneca Plc. Product
Table 113. Astrazeneca Plc. Recent Development
Table 114. CSL Limited Corporation Information
Table 115. CSL Limited Description and Business Overview
Table 116. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. CSL Limited Product
Table 118. CSL Limited Recent Development
Table 119. Emergent Biosolutions Corporation Information
Table 120. Emergent Biosolutions Description and Business Overview
Table 121. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Emergent Biosolutions Product
Table 123. Emergent Biosolutions Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Pneumonia Vaccine Players
Table 128. Pneumonia Vaccine Customers List
Table 129. Pneumonia Vaccine Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumonia Vaccine Product Picture
Figure 2. Global Pneumonia Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Pneumococcal Conjugate Vaccine (PCV13) Product Picture
Figure 4. Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
Figure 5. Global Pneumonia Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Pneumonia
Figure 7. Meningitis
Figure 8. Sepsis
Figure 9. Pneumonia Vaccine Report Years Considered
Figure 10. Global Pneumonia Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Pneumonia Vaccine Sales 2015-2026 (K Doses)
Figure 12. Global Pneumonia Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Pneumonia Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Pneumonia Vaccine Sales Market Share by Region in 2019
Figure 15. Global Pneumonia Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Pneumonia Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Pneumonia Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Pneumonia Vaccine Revenue in 2019
Figure 19. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 22. Global Pneumonia Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Pneumonia Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Pneumonia Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Pneumonia Vaccine Sales Market Share by Application in 2019
Figure 27. Global Pneumonia Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Pneumonia Vaccine Revenue Market Share by Application in 2019
Figure 29. Japan Pneumonia Vaccine Sales Growth Rate 2015-2026 (K Doses)
Figure 30. Japan Pneumonia Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. Japan Pneumonia Vaccine Market Share in Global Market 2015-2026
Figure 32. Japan 5 and 10 Largest Pneumonia Vaccine Players Market Share by Revenue in Pneumonia Vaccine in 2019
Figure 33. Japan Pneumonia Vaccine Revenue Share by Type (2015-2020)
Figure 34. Japan Pneumonia Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Japan Pneumonia Vaccine Revenue Share by Application (2015-2020)
Figure 36. Japan Pneumonia Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 38. North America Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 40. North America Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 41. U.S. Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 42. U.S. Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Canada Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 46. Europe Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 48. Europe Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 49. Germany Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Germany Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. France Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 54. U.K. Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 56. Italy Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Russia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 60. Asia Pacific Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Pneumonia Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Pneumonia Vaccine Revenue Market Share by Region in 2019
Figure 63. China Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 64. China Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. Japan Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. South Korea Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. India Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Australia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Taiwan Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Indonesia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Thailand Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 80. Malaysia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 82. Philippines Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 84. Vietnam Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 86. Latin America Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 88. Latin America Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 89. Mexico Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 90. Mexico Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 92. Brazil Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 94. Argentina Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 96. Middle East and Africa Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 100. Turkey Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 102. Saudi Arabia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 104. U.A.E Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Pneumonia Vaccine Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
  • Global Mebendazole Market Growth 2020-2025
    Published: 29-Oct-2020        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Mebendazole market will register a 5.8%% CAGR in terms of revenue, the global market size will reach $ 129.4 million by 2025, from $ 103.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Mebendazole business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Mebendazole market by product type, applic......
  • Global and China Atypical Hemolytic Uremic Syndrome Drug Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 127
    Atypical Hemolytic Uremic Syndrome Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Atypical Hemolytic Uremic Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Typ......
  • Global and China Nociceptin Receptor Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 133
    Nociceptin Receptor market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nociceptin Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Nociceptin Receptor market is seg......
  • Global and Japan Antibodies Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 130
    Antibodies market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Antibodies market is segmented into - Monocl......
  • Global and United States Rabies Treatment Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 132
    Rabies Treatment market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Rabies Treatment market is segmented in......
  • Global and China Becker Muscular Dystrophy Drug Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 129
    Becker Muscular Dystrophy Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Becker Muscular Dystrophy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Becker Musc......
  • Global and China Obsessive-Compulsive Disorder Treatment Market Size, Status and Forecast 2020-2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 96
    Global Obsessive-Compulsive Disorder Treatment Scope and Market Size Obsessive-Compulsive Disorder Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Obsessive-Compulsive Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.......
  • Global and United States Primary Biliary Cirrhosis Drug Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 130
    Primary Biliary Cirrhosis Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Primary Biliary Cirrhosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Primary Bil......
  • (Post-pandemic Era) - Global Hydroxychloroquine Sulfate Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 27-Oct-2020        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs